Artículos del autor

solaci

Structural heart disease

Is Rehospitalization a Relevant Factor after Aortic Valve Replacement?

Patients with severe symptomatic aortic stenosis treated with aortic valve replacement might still present cardiac failure, even...
solaci -
Institutional News

The Most Important Articles of 2022 in Peripheral Vascular Disease

Discover the most important scientific articles of 2022 in peripheral vascular disease in our website. EMINENT Trial |...
solaci -
Antiplatelet

Is it Possible to Reduce DAPT Time in Diabetic Patients?

Short-duration dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with DES is growing steadily, especially for...
solaci -
Coronary disease

Left Main Coronary Artery PCI Using State-of-the-Art Zotarolimus-Eluting Stents

Percutaneous coronary intervention (PCI) to the left main coronary artery (LMCA) with drug-eluting stent implantation is currently...
solaci -
Aorta

Intervention in Patients with Takayasu Arteritis: Rescue Therapy or an Alternative Complementary to Immunosuppressive Therapy?

Takayasu arteritis (TAK) is an uncommon granulomatous large-vessel vasculitis that affects the aorta and its primary branches. The...
solaci -
Institutional News

The Most Important Articles of 2022 in Coronary disease

Discover the most important scientific articles of 2022on coronary disease in our website. An Abbreviated Dual Antiplatelet Regimen...
solaci -
Institutional News

The Most Important Articles of 2022 in Structural Heart Disease

Discover the most read scientific articles on interventional cardiology of 2022 in our website. We Should Treat Significant...
solaci -
Acute coronary syndromes

Can We Use DAPT for 3 Months in Acute Coronary Syndrome?

Current guidelines recommend 12-month dual antiplatelet therapy (DAPT) after DES stenting for acute coronary syndrome (ACS) because...
solaci -